These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4106130)

  • 41. Reticulated multifocal fixed drug eruption due to mefenamic acid - a new morphological pattern.
    Dar NR; Masood S; Mustafvi SA
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):562-3. PubMed ID: 16181578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal fixed drug eruption due to mefenamic acid: Report of a case and a review.
    Zaouak A; Ben Brahim E; Ben Tanfous A; Koubaa W; Sahnoun R; Hammami H; Fenniche S
    Therapie; 2018 Oct; 73(5):433-435. PubMed ID: 29525693
    [No Abstract]   [Full Text] [Related]  

  • 43. Caffeine potentiates the nephrotoxicity of mefenamic acid on the rat renal papilla.
    Champion de Crespigny P; Hewitson T; Birchall I; Kincaid-Smith P
    Am J Nephrol; 1990; 10(4):311-5. PubMed ID: 2240058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug-induced immunological abnormalities].
    Fujimoto H; Fukuoka Y
    Rinsho Byori; 1980 Jan; 28(Spec No):70-9. PubMed ID: 7382113
    [No Abstract]   [Full Text] [Related]  

  • 45. Rare adverse reactions to nonsteroidal antiinflammatory drugs.
    O'Brien WM; Bagby GF
    J Rheumatol; 1985 Apr; 12(2):347-53. PubMed ID: 3897536
    [No Abstract]   [Full Text] [Related]  

  • 46. Multifocal fixed drug eruption probably induced by mefenamic acid.
    Pérez-Pérez L; García-Gavín J; Allegue F; Zulaica A
    Actas Dermosifiliogr; 2013 Jan; 104(1):85-7. PubMed ID: 22824351
    [No Abstract]   [Full Text] [Related]  

  • 47. A case of cardiac arrest following oral 250 mg. mefenamic acid.
    Leong LL
    Med J Malaysia; 1976 Mar; 30(3):229-37. PubMed ID: 1085401
    [No Abstract]   [Full Text] [Related]  

  • 48. Oesophageal ulceration associated with ingestion of mefenamic acid capsules.
    Katsinelos P; Dimiropoulos S; Vasiliadis T; Fotiadis G; Xiarchos P; Eugenidis N
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1431-2. PubMed ID: 10654808
    [No Abstract]   [Full Text] [Related]  

  • 49. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
    Holmes EL
    Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006
    [No Abstract]   [Full Text] [Related]  

  • 50. 'Dalmatian dog'-like skin eruption (two cases of multifocal fixed drug eruption induced by mefenamic acid).
    Rallis E; Rigopoulos D; Anyfantakis V; Kalogirou O; Christophidou E; Papadakis P; Katsambas A
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):753-5. PubMed ID: 16268887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of Mefacit on the liver of albino rats: observation of histochemical reactions].
    Czerny K; Celej P; Dowgird E
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():21-7. PubMed ID: 6086027
    [No Abstract]   [Full Text] [Related]  

  • 52. Delivery system for mefenamic acid based on the nanocarrier layered double hydroxide: Physicochemical characterization and evaluation of anti-inflammatory and antinociceptive potential.
    Cunha VR; Guilherme VA; de Paula E; de Araujo DR; Silva RO; Medeiros JV; Leite JR; Petersen PA; Foldvari M; Petrilli HM; Constantino VR
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():629-38. PubMed ID: 26478354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-steroidal anti-inflammatory drugs in elderly people. Mefenamic acid is more dangerous than most.
    Grant DJ; MacConnachie AM
    BMJ; 1995 Aug; 311(7001):392. PubMed ID: 7640566
    [No Abstract]   [Full Text] [Related]  

  • 54. Mefenamic acid enteropathy.
    Isaacs PE; Sladen GE; Filipe I
    J Clin Pathol; 1987 Oct; 40(10):1221-7. PubMed ID: 3680546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
    Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Iatrogenic pathology in hematology].
    Brunetaud JM; Coudoux P; Geoffroy H
    Maroc Med; 1972 Mar; 52(555):135-47. PubMed ID: 4114478
    [No Abstract]   [Full Text] [Related]  

  • 57. [Liver involvement during tolphenamic acid therapy].
    Mickley H; Amtrup F
    Ugeskr Laeger; 1981 Aug; 143(32):2036-7. PubMed ID: 7314269
    [No Abstract]   [Full Text] [Related]  

  • 58. Fixed drug eruption caused by mefenamic acid: a case series and diagnostic algorithms.
    Handisurya A; Moritz KB; Riedl E; Reinisch C; Stingl G; Wöhrl S
    J Dtsch Dermatol Ges; 2011 May; 9(5):374-8. PubMed ID: 21366861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid.
    Somchit N; Sanat F; Gan EH; Shahrin IA; Zuraini A
    Singapore Med J; 2004 Nov; 45(11):530-2. PubMed ID: 15510325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mefenamic acid: A possible cause of drug-induced acute pancreatitis.
    Wurm S; Schreiber F; Spindelboeck W
    Pancreatology; 2015; 15(5):570-572. PubMed ID: 26347329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.